1770 NEOADJUVANT SHORT-TERM INTENSIVE INTRAVESICAL MITOMYCIN C REGIMEN COMPARED TO STANDARD SCHEDULE FOR LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER. A RANDOMIZED PHASE II STUDY